Stay updated on Pembrolizumab in Recurrent PCNSL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent PCNSL Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:35:27.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details and navigation with an access-block message. This indicates the study record is currently inaccessible on this page.
    Difference
    18%
    Check dated 2026-09-20T20:33:20.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new site revision label v3.6.6 was added, replacing the previous v3.6.5. This indicates a small deployment to the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-08-30T11:29:07.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.4 to v3.6.5, indicating a minor update to the page template or content-management system. This update does not modify study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-09T00:41:25.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page’s revision identifier was updated from v3.6.3 to v3.6.4. This indicates the study page has been refreshed to a newer revision.
    Difference
    0.1%
    Check dated 2026-07-25T17:07:25.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The page now displays an updated revision tag from v3.6.2 to v3.6.3, indicating a recent backend/frontend update to the page.
    Difference
    0.1%
    Check dated 2026-07-04T06:00:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent PCNSL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.